Summary
Coronary artery disease is the leading cause of death in the United States. One common treatment is the coronary bypass surgery, which is performed on about 350,000 patients in the United States each year. This surgery is considered the gold standard treatment for patients with disease in multiple coronary arteries. Vein grafts are used as bypass conduits in majority of these surgeries and have unacceptably high failure rates leading to reoperation and increased risk of complications. The underlying mechanisms of vein graft failure remain poorly understood. This Faculty Early Career Developmen
